CombiMatrix and Merck both plan some cutting

Merck closing facilities in New Jersey, and CombiMatrix in Washington
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
After announcing last week its plans to restructure operations and seek a new CEO, microarray technologies and molecular diagnostics company CombiMatrix now says that it will close its facility in Mukilteo, Wash., and consolidate itscorporate activities in Irvine, Calif. An unspecifiednumber of jobs will be cut in the process. CombiMatrix noted in papers filed with the U.S.Securities and Exchange Commission that it expects the process ofshutting down the Washington operations to take from six to eight weeks.
 
Around the same time came word from sources at Merck that as aresult of last year's merger with Schering Plough, the company is goingto consolidate office space and operations in New Jersey, at Roseland, Union and Lafayette. Reportedly, the Roseland andLafayette sites will close in 2010, while the Union facility will phaseout by the end of 2012. No specific numbers have been offered as to how many willlose their jobs, but it apparently will be a mix of people whowork in R&D, such as in Lafayette, where the Schering-Plough ResearchInstitute has offices, as well as manufacturing personnel and others.
 


About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up illustration of clustered, irregularly shaped 3D cell structures resembling organoids, displayed in a blue-toned background.
Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.
Illustration of a glowing human brain with interconnected neural networks and bright data points, set against a dark, digital background.
Take a closer look at modern techniques that reveal when, where, and how neurons communicate in real time.
Gloved hand holding a petri dish containing red liquid culture medium against a light blue background.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue